

Cover Story
Returning to Houston for a town hall meeting at MD Anderson on Sept. 27, Peter Pisters, the institution's freshly-appointed president, hit every note a guy in his position needed to hit: baseball, football, shared values, shared governance, book clubs, reminiscences on growing up nerdy in Canada, the story of how he met his wife, anecdotes from taking care of MD Anderson patients during Hurricane Rita.
By Matthew Bin Han Ong
In Brief


Drugs & Targets


Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final













